Papillomaviral expression inhibitors

Details Papillomaviral expression inhibitors Papillomaviral expression inhibitors

1995-06-06

1997-10-07

Robinson, Douglas W.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

514 44, 4352351, A61K 3800, A61K 3170, C12N 700

Patent

active

056748353

ABSTRACT:
A method of inhibiting the growth of a virus, the DNA of the virus including the nucleic acid sequence 5' ACCXNNNPyCGGTXY3', wherein each N, X, and Y is, independently, any nucleotide, and Py is C or T, the nucleic acid sequence being capable of binding to a protein encoded by the DNA of the virus, the protein, upon binding to the nucleic acid sequence, being capable of causing the enhancement of the transcription of DNA of the virus, the method including inhibiting the protein from binding to the nucleic acid sequence to repress the transcription of DNA of said virus to inhibit the growth of the virus.

REFERENCES:
patent: 4775630 (1988-10-01), Tibbetts et al.
Ahola et al., Nucleic Acids Res., vol. 11, No. 9, pp. 2639-2650 (1983).
Androphy et al., "Bovine papillomavirus E2 trans-activating gene product binds to specific sites in papillomavirus DNA," Nature 325:70-73 (1987).
Calabretta, B., Cancer Res., vol. 51, pp. 4505-4510 (1991).
Chen et al., "The primary structure and genetic organization of the bovine papillomavirus type 1 genome," Nature 299:529-534 (1982).
Goodarzi, G. et al., Biol. Abstr., vol. 94, pp. AB-239, Abstract 2262 (1991).
Hill et al., Appl. Environ. Microbiol., vol. 50, No. 5, pp. 1187-1191 (1985).
Lambert et al., "A Transcriptional Repressor Encoded by BPV-1 Shares a Common Carboxy-Terminal Domain with the E2 Transactivator," Cell 50:69-78 (1987).
Lusky et al., "Characterization of the Bovine Papilloma Virus Plasmid Maintenance Seqeuences," Cell 36:391-401 (1984).
Moskaluk et al., "The E2 `gene` of bovine papillomavirus encodes an enhancer-binding protein," Proc. Nat. Acad. Sci. USA 84:1215-1218 (1987).
Olson, C., In: The Papovaviridae, vol. 2, ed. N. Salzman et al., Plenum Press, NY, pp. 39-66 (1987).
Peterson et al., J. Infect. Diseases, vol. 153, No. 4, pp. 757-762 (1986).
Varley et al., Nucleic Acids Res., vol. 12, No. 17, pp. 6727-6739 (1984).
Spalholz et al., J. Virology, vol. 61, No. 7, pp. 2128-2137 (1987).
Spalholz et al., "Transactivation of a Bovine Papilloma Virus Transcriptional Regulatory Element by the E2 Gene Product," Cell 42:183-191 (1985).
Stenlund et al., "Messenger RNAs from the Transforming Region of Bovine Papilloma Virus Type I," J. Mol. Biol. 185:541-554 (1985).
Tidd, D.M., Anticancer Res., vol. 10, pp. 1169-1182 (1990).

Affiliated with

Also associated with

Rating

Papillomaviral expression inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Papillomaviral expression inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Papillomaviral expression inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2357336